---
title: "MolTrace — Executive One-Pager"
subtitle: "AI-Native Scientific Intelligence for Pharmaceutical R&D"
version: "2026-06-13"
audience: "Pharmaceutical, biotech, CRO, and academic R&D leadership"
length: "Single page (≈500 words)"
---

# MolTrace

### AI-native scientific intelligence for chemistry and pharmaceutical R&D

> *"Every number in your regulatory dossier traces back to its raw spectrum, its processing recipe, its literature citation, and the human who signed it off."*

---

## The Problem in One Paragraph

Routine NMR / LC-MS structure elucidation in pharma still consumes **6–48 hours of analyst time per compound**, leaves no machine-readable chain of custody from raw FID to dossier sentence, and produces evidence that today's tightening regulatory frameworks (FDA AI Credibility 2025, EMA AI reflection paper, ICH Q2(R2)) are increasingly hard to satisfy. The status-quo toolchain — desktop processing apps, spreadsheets, email-attached PDFs — was not designed for the multi-modal, audit-first, reproducible workflow regulators now expect.

## The MolTrace Solution

A multi-tenant SaaS platform with three integrated programs sharing one evidence engine, one immutable raw-data vault, and one provenance layer:

| Program | What it does |
|---|---|
| **SpectraCheck** | 40-layer NMR + MS evidence engine: 1H, 13C, 2D NMR, raw FID (Bruker / Agilent-Varian), HRMS, MS/MS, LC-MS features. Categorises peaks against literature-backed shift windows. Ranks candidates with DP4/DP5-class methods. Includes an opt-in industry-standard GSD detector that has cleared its production promotion gate against three independent reference corpora — NMRShiftDB2, an HMDB-style synthetic corpus, and a 100-fixture real-instrument HMDB corpus (95 % parseable, 93 % solvent auto-detect) — plus a multiplet analyser that recovers J-coupling structure (quinine within 0.3 Hz of literature; a known hidden 11.4 Hz coupling benchmark resolved), now fed into the unified confidence engine as a candidate-discriminating J-coupling agreement layer. |
| **Regentry** | Dossier scaffolding, ICH/FDA/EMA-aligned audit packs, human-in-the-loop release gating, AI-supported question/answer routing. One-screen **Impurity Assessment** computes ICH Q3A/B, Q3C, Q3D, M7 and FDA CPCA nitrosamine limits as one report, each line traceable to its regulatory basis. A **Process Capability & Trending** view charts a parameter's batch series (Cp/Cpk + Western Electric / CUSUM / EWMA) to flag drift before a spec breach. |
| **Reaction Optimization** | Bayesian optimisation, multi-objective response-surface modelling, design-of-experiments under mechanistic constraints, integrated reaction-history provenance, and per-experiment green-chemistry metrics (E-factor, atom economy, PMI, solvent green-score). |

## What Makes MolTrace Different

- **Evidence-first.** Every UI claim is one click from its source spectrum file, peak, SMILES, citation, and reviewer.
- **Immutable raw vault.** Vendor archives are SHA-256 hashed on upload and never overwritten; every processing run is a derived, recipe-hashed artifact.
- **Multi-modal by default.** NMR + HRMS + MS/MS + LC-MS are one evidence stack; cross-modal contradictions surface as first-class warnings.
- **Human-in-the-loop, never autonomous.** No regulatory document releases without explicit reviewer signoff — aligned with the FDA AI Credibility Framework (2025) and EMA AI reflection paper.
- **A compounding data moat — gets smarter the more you use it, never overrides the science.** Every AI output carries a one-click *"Was this correct?"* control; each reviewer judgement becomes an immutable, model-version-stamped record that seeds the next training round. An advisory reward model triages where the model is weakest, disagreement sampling points scarce expert review at the most informative spectra, and the override rate is tracked as it falls — auditable proof the model is improving; new models roll out champion-vs-challenger with measured-dominance promotion, human sign-off, no auto-deploy, and instant rollback — while the deterministic verifier still arbitrates every call. The loop compounds your proprietary advantage on data a competitor without your install base cannot buy.
- **Open-science under the hood.** RDKit, nmrglue, mzML, FastAPI, Next.js — no proprietary file-format lock-in.

## Quantified Outcomes (typical 8-FTE analytical team, 600 analyses/year)

- **5–10×** compression of time-to-structure (minutes vs. hours)
- **60–80 %** reduction in time-to-dossier
- **> 98 %** report-from-raw reproducibility rate
- **Days→minutes** for audit-cycle question turnaround
- **~$300K/year** recouped FTE cost (mid-complexity small-molecule workflows)

## Compliance Posture

Designed to support SOC 2 Type II, ICH Q2(R2), GDPR, and GxP validation · GAMP 5 (Appendix D11) & ICH Q2(R2) validation-document generation + a regenerable per-release validation package (requirement→risk→test traceability + IQ/OQ/PQ-from-CI evidence) with validated-state change control · enterprise single sign-on (per-organization OpenID Connect, optional enforce-SSO) + SCIM 2.0 auto-provisioning/deprovisioning + MFA (TOTP + WebAuthn/passkeys, step-up re-auth for signing) + rotating refresh tokens with reuse detection & immediate revocation + centralized policy-as-code authorization (deny-by-default) + Argon2id password hashing (memory-hard KDF) + field-level envelope encryption (KMS-wrapped AES-256-GCM data keys, rotation + BYOK seam) + secure-SDLC CI gates (secret-scanning + SAST + dependency/license SCA + IaC scanning; criticals block, findings tracked) + signed supply chain (CycloneDX SBOM per build + SLSA provenance, keyless Sigstore, verify-at-deploy) + HSTS/TLS security headers + tamper-evident hash-chained audit ledger (HMAC-anchored, verifiable) + 21 CFR Part 11-supporting e-signatures (server-authoritative signer identity, record-content-bound so a signature can't be transferred, durable §11.50 manifestation, integrity-verifiable) + role-based access control · content-hash reproducibility gate · fail-closed deployment gate (dominance + audit chain + no gold-set leakage) · production drift monitoring · ALCOA+ data-integrity primitives baked into every layer of the architecture (reason-for-change capture + reversible-by-record soft-deletes on regulated records, server-sourced timestamps, and a fail-closed write-once raw-data vault).

## What's Next

- **Pilot programs** open for pharmaceutical R&D, CRO, and academic analytical groups
- **Integration packages** for Bruker / Agilent / Waters / Thermo instrumentation
- **Regulatory-affairs onboarding** with dedicated FDA AI Credibility Framework mapping

---

**Read the full white paper.** Hybrid (5,700 words), Sales-led (≈4,000 words), and Technical-reviewer (≈7,500 words) variants available. Request access for pilot evaluation, technical due-diligence, or regulatory-affairs briefings.

*© 2026 MolTrace Technologies, Inc.*
